COVID-19 News & HydroxychloroquineJuly 20, 2020 | Oncology Family Medicine/General Practice Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 No effective oral therapy exists for the outpatient treatment of COVID-19. Hydroxychloroquine has in vitro activity against SARS-CoV-2 and has been proposed as a potentially effective treatment. This randomized double-blind, placebo-controlled trial investigated whether hydroxychloroquine could reduce COVID-19 severity in adult outpatients. Read full article Allergy & Immunology COVID-19 Spurs Telemedicine, Furloughs, Retirement The survey demonstrates the rapid adoption of telemedicine, with 48% of physicians respondents reporting that they are now treating patients through telemedicine, but the pandemic is also creating significant disruption as some physicians are furloughed and others consider practice changes. Read full article Allergy & Immunology COVID-19: The Worst May Be Yet to Come In this editorial from The Lancet, the authors dissect the 160,000 new cases reported each day worldwide since June 25 and how these numbers illustrate a worrying pattern of the world facing a worsening multipolar pandemic despite the nuanced subnational picture level. Read full article
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS